Development and characterisation of KRASmulti inhibitors for the treatment of KRAS mutant pancreatic ductal adenocarcinoma

被引：0
|
作者：
Tedeschi, Antonio
Schaaf, Otmar
Gmachl, Michael
Herdeis, Lorenz
Rocchetti, Francesca
Popow, Johannes
Schischlik, Fiorella
Gerlach, Daniel
Lipp, Jesse
Broker, Joachim
Mantoulidis, Andreas
Smethurst, Chris
Kessler, Dirk
Boettcher, Jark
Wunberg, Tobias
Santoro, Valeria
Waterson, Alex
Phan, Jason
Little, Andrew
Abbott, Jason
Sun, Qi
Fesik, Stephen
Mcconnell, Darryl
Pearson, Mark A.
Kraut, Norbert
Rudolph, Dorothea
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 02期
关键词：
D O I：
10.1158/1538-7445.PANCA2023-B103
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B103
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung Adenocarcinoma
    Kohler, Jens
    Catalano, Marco
    Ambrogio, Chiara
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (05) : 558 - 574
  • [32] KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
    Zhang, Zining
    Zhang, Heng
    Liao, Xiang
    Tsai, Hsiang-i
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [33] Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma
    Shen, Xuqing
    Niu, Ningning
    Xue, Jing
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2023, 11 (04) : 322 - 329
  • [34] Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
    Liu, Yu-Huei
    Hu, Chun-Mei
    Hsu, Yuan-Sheng
    Lee, Wen-Hwa
    CELL DEATH & DISEASE, 2022, 13 (09)
  • [35] Concentrations of trace elements and KRAS mutations in pancreatic ductal adenocarcinoma
    Gomez-Tomas, Alvaro
    Pumarega, Jose
    Alguacil, Juan
    Amaral, Andre F. S.
    Malats, Nuria
    Pallares, Natalia
    Gasull, Magda
    Porta, Miquel
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2019, 60 (08) : 693 - 703
  • [36] Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
    Yu-Huei Liu
    Chun-Mei Hu
    Yuan-Sheng Hsu
    Wen-Hwa Lee
    Cell Death & Disease, 13
  • [37] KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
    Yu Shuang-Ni
    Ma Yi-Hui
    Zhao Wu-Gan
    Jin Xiang-Lan
    Yang Hai-Yan
    Liu Ping-Ping
    Chen Jie
    慢性疾病与转化医学（英文）, 2016, 2 (04)
  • [38] Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
    de Jesus, Victor Hugo Fonseca
    Mathias-Machado, Maria Cecilia
    de Farias, Joao Paulo Fogacci
    Aruquipa, Marcelo Porfirio Sunagua
    Jacome, Alexandre A.
    Peixoto, Renata D'Alpino
    CANCERS, 2023, 15 (20)
  • [39] KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma
    Mahmoud Yousef
    Abdelrahman Yousef
    Mark W. Hurd
    Ashwathy Pillai
    Saikat Chowdhury
    Rebecca Snyder
    Mark Knafl
    Ryan L. Lewis
    Paul M. Roy
    Mohammad Fanaeian
    Sali Albarouki
    Luca F. Castelnovo
    Jennifer Peterson
    Brandon G. Smaglo
    Robert A. Wolff
    Shubham Pant
    Jason Willis
    Ryan Huey
    Michael Overman
    Ching-Wei Tzeng
    Michael P. Kim
    Naruhiko Ikoma
    Jess E. Maxwell
    Matthew H. G. Katz
    Huamin Wang
    Anirban Maitra
    Eugene Koay
    Ethan B. Ludmir
    Anthony Chen
    Camila Lopez
    Haoqiang Ying
    John Paul Shen
    Dan Zhao
    Journal of Hematology & Oncology, 18 (1)
  • [40] Oncogenic Kras induces histone acetylation in pancreatic ductal adenocarcinoma
    Carrer, Alessandro
    Lee, Joyce V.
    Shah, Supriya
    Snyder, Nathaniel W.
    Jackson, Ellen
    Aiello, Nicole M.
    Garcia, Benjamin A.
    Chodosh, Lewis A.
    Stanger, Ben Z.
    Blair, Ian A.
    Wellen, Kathryn E.
    CANCER RESEARCH, 2015, 75
12345